Wednesday, December 3, 2008 - 6:17PM EST

Review Articles

11. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.

Author
Proudman SM; Stevens WM; Sahhar J; Celermajer D;
Institution
Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. sproudman@internode.on.net
Journal
Intern Med J. 2007 Jul;37(7):485-94.
Abstract URL
Click here to view abstract

12. The development of systemic sclerosis classification criteria.

Author
Walker JG; Pope J; Baron M; Leclercq S; Hudson M; Taillefer S; Edworthy SM; Nadashkevich O; Fritzler MJ;
Institution
Faculty of Medicine, University of Calgary, 3330 Hospital Dr NW, T2N 4N1, Calgary, AB, Canada.
Journal
Clin Rheumatol. 2007 Sep;26(9):1401-9. Epub 2007 Feb 7.
Abstract URL
Click here to view abstract

13. Treatment of complications associated with systemic sclerosis.

Author
Moore SC; Desantis ER;
Institution
Robert Wood Johnson University Hospital (RWJUH), New Brunswick, NJ, USA.
Journal
Am J Health Syst Pharm. 2008 Feb 15;65(4):315-21.
Abstract URL
Click here to view abstract

14. Gastric and enteric involvement in progressive systemic sclerosis.

Author
Ebert EC;
Institution
UMDNJ-Robert Wood Johnson Medical School, One Robert Wood Johnson Place, New Brunswick, NJ, USA. ebertec@umdnj.edu
Journal
J Clin Gastroenterol. 2008 Jan;42(1):5-12.
Abstract URL
Click here to view abstract

15. Systemic sclerosis and malignancy: a review of the literature.

Author
Wooten M;
Institution
VA Northern Indiana Healthcare System, Indiana University School of Medicine, Fort Wayne, Indiana 46805, USA. marc.wooten@va.gov
Journal
South Med J. 2008 Jan;101(1):59-62.
Abstract URL
Click here to view abstract

16. Systemic and localized scleroderma.

Author
Chung L; Lin J; Furst DE; Fiorentino D;
Institution
Department of Dermatology, Stanford University School of Medicine, CA 94305, USA.
Journal
Clin Dermatol. 2006 Sep-Oct;24(5):374-92.
Abstract URL
Click here to view abstract

17. Localized and systemic forms of scleroderma in adults and children .

Author
Atzeni F; Bardoni A; Cutolo M; Hunzelmann N; Krieg T; Martini G; Montecucco C; Olski TM; Secchi ME; Valentini G; Zulian F; Sarzi-Puttini P;
Institution
Rheumatology Unit, L Sacco University Hospital, Milan, Italy.
Journal
Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S36-45.
Abstract URL
Click here to view abstract

18. Treatment of systemic sclerosis.

Author
Allanore Y; Kahan A;
Institution
Rheumatology A Department, Cochin Teaching Hospital, Assistance Publique-Hopitaux de Paris, Paris 5 University, 27, rue du faubourg Saint-Jacques, 75014 Paris, France. yannick.allanore@cch.aphp.fr
Journal
Joint Bone Spine. 2006 Jul;73(4):363-8. Epub 2006 Jan 6.
Abstract URL
Click here to view abstract

19. Systemic and localized scleroderma in children: current and future treatment options.

Author
Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ;
Institution
Hospital for Special Surgery, Division of Pediatric Rheumatology, New York, New York, USA.
Journal
Paediatr Drugs. 2006;8(2):85-97.
Abstract URL
Click here to view abstract

20. Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis.

Author
Oldfield V; Lyseng-Williamson KA;
Institution
Adis International Inc., Yardley, Pennsylvania 19067, USA. demail@adis.com
Journal
Am J Cardiovasc Drugs. 2006;6(3):189-208.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4